METHOD FOR DETERMINING EFFECTIVENESS OF DOSE OF DIETARY SUPPLEMENT LIGNARIUS IN PATIENTS WITH FIBROCYSTIC MASTOPATHY Russian patent published in 2023 - IPC A61B8/08 G01N33/48 

FIELD: medicine; gynaecology; mammology.

SUBSTANCE: invention can be used to determine the effectiveness of the dose of Lignarius dietary supplement in patients with fibrocystic mastopathy. To do this, before taking dietary supplements, the values of the atherogenic index, total cholesterol, LDL and triglycerides are identified in the venous blood. Then, 3 months after taking the dietary supplement Lignarius at a dose of 30 mg per day, the indicated venous blood parameters are identified again. With a decrease in the value of the atherogenic index after treatment by 30.1%, total cholesterol by 20.7%, LDL by 31.1% and triglycerides by 3.3%, it is concluded that taking the dietary supplement Lignarius at a dose of 30 mg per day is effective.

EFFECT: invention makes it possible to evaluate the effectiveness of taking 30 mg of Lignarius dietary supplement per day based on the analysis of dynamic changes in parameters before and after taking the dietary supplement for three months in this category of women.

1 cl, 1 ex, 1 tbl